amifostine anhydrous and transforming growth factor beta

amifostine anhydrous has been researched along with transforming growth factor beta in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Anscher, MS; Brizel, DM; Feng, QF; Rabbani, ZN; Samulski, TV; Vujaskovic, Z1
Egami, MI; Ferreira, AT; Franco, M; Kimura, ET; Segreto, HR; Segreto, RA; Silva, MR1
Filicko, J; Flomenberg, N; Lazarus, HM1
Damron, TA; Farnum, CE; Grant, W; Horton, JA; Margulies, B; Mathur, S; Spadaro, JA; Strauss, J1
Brizel, DM; Brizel, MB; Jackson, IL; Thrasher, BA; Vujaskovic, Z1

Reviews

1 review(s) available for amifostine anhydrous and transforming growth factor beta

ArticleYear
Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment.
    Bone marrow transplantation, 2003, Volume: 31, Issue:1

    Topics: Amifostine; Humans; Interleukin-11; Mucous Membrane; Stem Cell Transplantation; Transforming Growth Factor beta

2003

Other Studies

4 other study(ies) available for amifostine anhydrous and transforming growth factor beta

ArticleYear
Radioprotection of lungs by amifostine is associated with reduction in profibrogenic cytokine activity.
    Radiation research, 2002, Volume: 157, Issue:6

    Topics: Amifostine; Animals; Collagen; Cytokines; Ectodysplasins; Extracellular Matrix Proteins; Female; Lung; Membrane Proteins; Neoplasm Proteins; Radiation-Protective Agents; Rats; Rats, Inbred F344; Respiration; Time Factors; Transforming Growth Factor beta

2002
Amifostine does not prevent activation of TGFbeta1 but induces smad 7 activation in megakaryocytes irradiated in vivo.
    American journal of hematology, 2002, Volume: 71, Issue:3

    Topics: Amifostine; Animals; DNA-Binding Proteins; Immunohistochemistry; Male; Megakaryocytes; Mice; Mice, Inbred C57BL; Radiation-Protective Agents; Signal Transduction; Smad2 Protein; Smad3 Protein; Smad4 Protein; Smad7 Protein; Time Factors; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1; Whole-Body Irradiation

2002
Temporal changes in PTHrP, Bcl-2, Bax, caspase, TGF-beta, and FGF-2 expression following growth plate irradiation with or without radioprotectant.
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2004, Volume: 52, Issue:2

    Topics: Amifostine; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; Fibroblast Growth Factor 2; Growth Plate; Immunohistochemistry; Parathyroid Hormone-Related Protein; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Radiation-Protective Agents; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta

2004
Radioprotective effects of amifostine on acute and chronic esophageal injury in rodents.
    International journal of radiation oncology, biology, physics, 2007, Oct-01, Volume: 69, Issue:2

    Topics: Acute Disease; Amifostine; Animals; Antigens, Neoplasm; Body Weight; Chronic Disease; Drug Evaluation, Preclinical; Esophagus; Female; Integrins; Macrophage Activation; Mucous Membrane; Oxidative Stress; Radiation Injuries; Radiation-Protective Agents; Random Allocation; Rats; Rats, Inbred F344; Transforming Growth Factor beta

2007